While the hunt continues for "small molecule regulators," the use of indirect transcranial and intraocular and intranasal near-infrared photobiomodulation can be used to mitigate cell death and improve ATP production and cortical blood flow. When this type of therapy is combined with brainwave biofeedback training to normalize neural connectivity, it is possible to significantly modify both behavioral and cognitive symptoms associated with both aging and neurodegenerative disease. This is being borne out in our current trials in collaboration with Baylor Research Institute and in our clinical practice in Philadelphia.
Comments
Quietmind Foundation
While the hunt continues for "small molecule regulators," the use of indirect transcranial and intraocular and intranasal near-infrared photobiomodulation can be used to mitigate cell death and improve ATP production and cortical blood flow. When this type of therapy is combined with brainwave biofeedback training to normalize neural connectivity, it is possible to significantly modify both behavioral and cognitive symptoms associated with both aging and neurodegenerative disease. This is being borne out in our current trials in collaboration with Baylor Research Institute and in our clinical practice in Philadelphia.
View all comments by Marvin BermanMake a Comment
To make a comment you must login or register.